A
Arrowhead Pharmaceuticals
Biotech & Life Sciences · Pasadena, United States · Founded 2003 Unicorn
Global footprint
Where Arrowhead Pharmaceuticals has talent and traffic
(1 of 737 staff)
across markets
Patent intelligence
$246M patent portfolio · 153 active families
Where Arrowhead Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Arrowhead Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Arrowhead Pharmaceuticals's 3 investments and acquisitions.
Every disclosed deal where Arrowhead Pharmaceuticals appeared as a backer or acquirer, 2006–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Arrowhead Pharmaceuticals's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Arrowhead Pharmaceuticals's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Arrowhead Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Arrowhead Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arrowhead Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.